Daraxonrasib Approval for Pancreatic Cancer
Daraxonrasib Approval brings a new FDA-approved treatment option for adults with metastatic pancreatic cancer.
Vepdegestrant FDA Approval Marks Cancer Breakthrough
Vepdegestrant FDA approval introduces a new targeted oral therapy for advanced breast cancer patients.